VolitionRx Ltd
VNRX
25 hedge funds and large institutions have $11.2M invested in VolitionRx Ltd in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
39% more funds holding
Funds holding: 18 → 25 (+7)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.08% less ownership
Funds ownership: 0.86% → 0.78% (-0.08%)
16% less capital invested
Capital invested by funds: $13.4M → $11.2M (-$2.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$354K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$270K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$263K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$190K |
| 5 |
Morgan Stanley
New York
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
-$970K |
| 2 |
BlackRock
New York
|
-$18.3K |
| 3 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$11K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9.36K |
| 5 |
LCM
Leisure Capital Management
Costa Mesa,
California
|
-$4.04K |
VNRX Hedge Fund Activity: Q1 2018 in Review
25 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2018, worth a combined $11.2M — down 16% from $13.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VNRX positions and 1 closed out — a net gain of 7 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Skylands Capital, opening a new position worth an estimated $354K. The largest seller was Lagoda Investment Management, cutting an estimated $970K.
- 25 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2018, up from 18 in Q4 2017.
- Funds reported $11.2M of VolitionRx Ltd stock for Q1 2018, down 16% quarter-over-quarter.
- 8 funds opened new VolitionRx Ltd positions in Q1 2018 and 1 closed out, a net change of +7 holders.
- The largest VolitionRx Ltd buyer in Q1 2018 was Skylands Capital, an estimated $354K added.
- The largest VolitionRx Ltd seller in Q1 2018 was Lagoda Investment Management, an estimated $970K sold.
Based on aggregated 13F filings for Q1 2018.